Re: Cost-Effectiveness of Pembrolizumab in Second-Line Advanced Bladder Cancer

M. Sarfaty, P. S. Hall, K. K.W. Chan, K. Virik, M. Leshno, N. Gordon, A. Moore, V. Neiman, E. Rosenbaum, D. A. Goldstein

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)1095
Number of pages1
JournalJournal of Urology
Issue number6
StatePublished - 1 Dec 2019
Externally publishedYes

ASJC Scopus subject areas

  • Urology

Cite this